Safety and efficacy of prothrombin complex concentrates for the treatment of coagulopathy after cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 147, Issue 3, 2014, Pages 1036-1040

  Song, Howard K ^a,b   Tibayan, Frederick A ^a   Kahl, Ed A ^a   Sera, Valerie A ^a   Slater, Matthew S ^a   Deloughery, Thomas G ^a   Scanlan, Mick M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CARDIAC SURGICAL PROCEDURES; COAGULANTS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PLATELET TRANSFUSION; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84894046456     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.11.020     Document Type: Conference Paper

References (31)

1. G. Despotis, C. Eby, and D.M. Lublin A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery Transfusion 48 2008 2S 30S
2. D. Paparella, S.J. Brister, and M.R. Buchanan Coagulation disorders of cardiopulmonary bypass: a review Intensive Care Med 30 2004 1873 1881
3. K. Karkouti, J. Callum, M.A. Crowther, S.A. McCluskey, J. Pendergrast, and G. Tait et al. The relationship between fibrinogen levels after cardiopulmonary bypass and large volume red cell transfusion in cardiac surgery: an observational study Anesth Analg 117 2013 14 22
4. C.F. Weber, M. Klages, and K. Zacharowski Perioperative coagulation management during cardiac surgery Curr Opin Anaesthesiol 26 2013 60 64
5. M.C. Christensen, S. Krapf, A. Kempel, and C. von Heymann Costs of excessive postoperative hemorrhage in cardiac surgery J Thorac Cardiovasc Surg 138 2009 687 693
6. K. Karkouti, D.N. Wijeysundera, T.M. Yau, W.S. Beattie, E. Abdelnaem, and S.A. McCluskey et al. The independent association of massive blood loss with mortality in cardiac surgery Transfusion 44 2004 1453 1462
7. A. Vivacqua, C.G. Koch, A.M. Yousuf, E.R. Nowicki, P.L. Houghtaling, and E.H. Blackstone et al. Morbidity of bleeding after cardiac surgery: is it blood transfusion, reoperation for bleeding, or both? Ann Thorac Surg 91 2011 1780 1790
8. A. Alfirevic, M. Xu, D. Johnston, P. Figueroa, and C.G. Koch Transfusion increases the risk for vasoplegia after cardiac operations Ann Thorac Surg 92 2011 812 819
9. Y.M. Bilgin, L.M.G. van de Watering, M.I.M. Versteegh, M.H.J. van Oers, E.C. Vamvakas, and A. Brand Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery Transfusion 51 2011 2603 2610
10. M. Ranucci, A. Pazzaglia, C. Bianchini, G. Bozzetti, and G. Isgro Body size, gender, and transfusions as determinants of outcome after coronary operations Ann Thorac Surg 85 2008 481 486
11. Society of Thoracic Surgeons Blood Conservation Guideline Task Force V.A. Ferraris, J.R. Brown, G.J. Despotis, J.W. Hammon, T.B. Reece, and S.P. Saha et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines Ann Thorac Surg 91 2011 944 982
12. M.E. Halkos, J.H. Levy, E. Chen, V.S. Reddy, O.M. Lattouf, and R.A. Guyton et al. Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery Ann Thorac Surg 79 2005 1303 1306
13. J.-F. Hardy, S. Belisle, and P. Van der Linden Efficacy and safety of activated recombinant factor VII in cardiac surgical patients Curr Opin Anaesthesiol 22 2009 95 99
14. K. Karkouti, W.S. Beattie, R. Arellano, T. Aye, J.S. Bussieres, and J.L. Callum et al. Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery Circulation 118 2008 331 338
15. K. Karkouti, W.S. Beattie, D.N. Wijeysundera, T.M. Yau, S.A. McCluskey, and M. Ghannam et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis Transfusion 45 2005 26 34
16. K.A. O'Connell, J.J. Wood, R.P. Wise, J.N. Lozier, and M.M. Braun Thromboembolic adverse events after use of recombinant human coagulation factor VIIa JAMA 295 2006 293 298
17. S. Romagnoli, S. Bevilacqua, S. Gelsomino, S. Pradella, L. Ghilli, and C. Rostagno et al. Small-dose recombinant activated factor VII (NovoSeven) in cardiac surgery Anesth Analg 102 2006 1320 1326
18. C. von Heymann, H. Hotz, W. Konertz, W.J. Kox, and C. Spies Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery J Cardiothorac Vasc Anesth 16 2002 615 616
19. O. Warren, K. Mandal, V. Hadjianastassiou, L. Knowlton, S. Panesar, and K. John et al. Recombinant activated factor VII in cardiac surgery: a systematic review Ann Thorac Surg 83 2007 707 714
20. M. Petricevic, B. Biocina, S. Konosic, and I. Burcar Haemostatic management in high-risk cardiac surgery: a role of recombinant factor VIIa (NovoSeven RT) Eur J Cardiothorac Surg 42 2012 606 607
21. C. Cromwell, and L.M. Aledort FEIBA: a prohemostatic agent Semin Thromb Hemost 38 2012 265 267
22. D. Green Complications associated with the treatment of haemophiliacs with inhibitors Haemophilia 5 Suppl 3 1999 11 17
23. M.W. Hilgartner, and G.L. Knatterud The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors Blood 61 1983 36 40
24. E.M. Kurczynski, and J.A. Penner Activated prothrombin concentrate for patients with factor VIII inhibitors N Engl J Med 291 1974 164 167
25. C.A. Leissinger, P.M. Blatt, W.K. Hoots, and B. Ewenstein Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature Am J Hematol 83 2008 137 143
26. M. Makris, M. Greaves, W.S. Phillips, S. Kitchen, F.R. Rosendaal, and E.F. Preston Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy Thromb Haemost 77 1997 477 480
27. R. Demeyere, S. Gillardin, J. Arnout, and P.F. Strengers Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study Vox Sang 99 2010 251 260
28. P.L. Turecek, K. Varadi, H. Gritsch, and H.P. Schwarz FEIBA: mode of action Haemophilia 10 Suppl 2 2004 3 9
29. J. Astermark, S.M. Donfield, D.M. DiMichele, A. Gringeri, S.A. Gilbert, and J. Waters et al. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study Blood 109 2007 546 551
30. P.O. Bonnet, B.S. Yoon, W.Y. Wong, K. Boswell, and B.M. Ewenstein Cost minimization analysis to compare activated prothrombin complex concentrate and recombinant factor VIIa for haemophilia patients with inhibitors undergoing major orthopaedic surgeries Haemophilia 15 2009 1083 1089
31. P. Diprose, M.J. Herbertson, D. O'Shaughnessy, and R.S. Gill Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study Br J Anaesth 95 2005 596 602